Maternal Lipids and Fetal Overgrowth: Making Fat from Fat.
Maternal Lipids and Fetal Overgrowth: Making Fat from Fat.
复制标题
DOI:
10.1016/j.clinthera.2018.08.007
复制
发表时间:
2018-10
影响因子:
3.2
通讯作者:
Hernandez TL
中科院分区:
文献类型:
--
作者:
Barbour LA;Hernandez TL
There is an increasing recognition that maternal glucose concentrations lower than those previously used to diagnosis gestational diabetes mellitus (GDM) and target for treatment can result in excess fetal growth. Yet, mothers with GDM who appear to have optimal glycemic control and mothers with obesity and normal glucose tolerance still have a significantly increased risk for delivering infants who are large-for-gestational-age (LGA), or even more importantly, who have increased adiposity at birth. What is less appreciated is that in addition to glucose, maternal lipids are also substrates for fetal fat accretion and that placental lipases can hydrolyze maternal triglycerides (TG) to free fatty acids (FFA) for fetal-placental availability. Maternal TG are 40–50% higher on average in mothers with obesity and GDM compared to normal-weight (NW) mothers early in pregnancy and are sustained at a higher level throughout gestation. Increasing evidence supports that maternal TG, both fasting (FTG) and postprandial (PPTG), are also predictors of newborn adiposity (newborn %fat), a risk factor for childhood obesity, and that early exposure is at least as strong of a risk factor as later exposure in mothers with obesity. In the setting of maternal nutrient excess and maternal insulin resistance, which lead to fetal hyperinsulinemia, excess FFA exposure to the fetus may result in lipid storage and fetal fat development in subcutaneous and possibly other depots. In this commentary, we provide further evidence to make a case for targeting maternal FTG and PPTG in mothers with obesity who have elevated TG in early pregnancy to determine whether a TG-lowering interventional approach might limit fetal overgrowth and potentially mitigate the intrauterine contribution towards childhood obesity and metabolic disease.
登录
查看更多内容
影响因子:
8.2
作者:
Desoye G;Nolan CJ
通讯作者:
Nolan CJ
DOI:
10.1016/s0002-9378(03)00828-7
发表时间:
2003-12-01
影响因子:
9.8
作者:
Catalano, PM;Thomas, A;Amini, SB
通讯作者:
Amini, SB
影响因子:
3.7
作者:
Barrett HL;Kubala MH;Scholz Romero K;Denny KJ;Woodruff TM;McIntyre HD;Callaway LK;Nitert MD
通讯作者:
Nitert MD
影响因子:
3.5
作者:
Di Cianni, G;Miccoli, R;Del Prato, S
通讯作者:
Del Prato, S
DOI:
10.1016/j.jpeds.2012.11.017
发表时间:
2013-05
期刊:
The Journal of pediatrics
影响因子:
--
作者:
Brumbaugh DE;Tearse P;Cree-Green M;Fenton LZ;Brown M;Scherzinger A;Reynolds R;Alston M;Hoffman C;Pan Z;Friedman JE;Barbour LA
通讯作者:
Barbour LA